Iridex (IRIX) Net Cash Flow Growth (3y) (2014 - 2026)
Iridex (IRIX) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 269.22% |
| 10 | Iridex | 13.34 Mn | 8.66 Mn | 4.30 Mn | 27.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 20.40% |
| Jan 3, 2026 | 31.47% |
| Sep 27, 2025 | 18.04% |
| Jun 28, 2025 | 46.33% |
| Mar 29, 2025 | 51.69% |
| Dec 28, 2024 | -28.36% |
| Mar 30, 2024 | -28.08% |
| Sep 30, 2023 | -91.01% |
| Jul 1, 2023 | -64.48% |
| Apr 1, 2023 | -23.22% |
| Dec 31, 2022 | -86.00% |
| Oct 1, 2022 | 7.28% |
| Jul 2, 2022 | -21.77% |
| Apr 2, 2022 | 6.88% |
| Jan 1, 2022 | 94.89% |
| Apr 3, 2021 | 92.04% |
| Sep 26, 2020 | 30.18% |
| Jun 27, 2020 | -12.21% |
| Mar 28, 2020 | -150.51% |
| Dec 28, 2019 | -26.38% |